Core Viewpoint - Company maintains an "outperform" rating for Ausnutria (01717), projecting steady revenue growth and significant profit increases from 2025 to 2027 [1][2] Financial Projections - Expected revenue for Ausnutria in 2025, 2026, and 2027 is 7.67 billion, 7.88 billion, and 8.04 billion CNY, reflecting year-on-year growth of 3.6%, 2.8%, and 2.1% respectively [1] - Projected net profit attributable to shareholders for the same years is 310 million, 340 million, and 390 million CNY, with growth rates of 21.0%, 8.0%, and 15.0% [1] - Earnings per share (EPS) are forecasted to be 0.18, 0.19, and 0.22 CNY [1] Market Performance - The overseas market has become the second growth engine for Ausnutria, with revenue growth of 54.2% in the Middle East and 138.7% in North America during the first half of 2025 [1][2] - The company has initiated an internal code system upgrade and inventory adjustments, which, while reducing short-term shipments, are expected to enhance product freshness and channel transparency [2] Strategic Focus - Ausnutria is advancing its internationalization strategy, particularly in the sheep milk powder segment, which is gaining traction in overseas markets [2] - The company has launched brands like Nutrition Care and 爱益森 in the nutrition segment, leveraging scientific strength for category breakthroughs [2] - The dual focus on cow and sheep milk products, along with a comprehensive nutrition strategy, positions Ausnutria for resilient growth in a complex market environment [2]

Investment Rating - The report maintains an "Outperform" rating for Ausnutria Dairy [2][14]. Core Insights - The overseas market is experiencing sustained high growth, becoming a significant growth engine for the company, with notable revenue increases in regions such as North America and the Middle East [5][12]. - The introduction of a childcare subsidy policy in China is expected to alleviate some pressures on the infant formula industry, although a full recovery will require more robust local stimulus measures [4][11]. - Ausnutria is actively expanding its international presence and enhancing its product offerings through a dual focus on goat and cow milk products, which is expected to drive long-term growth [6][13]. Financial Performance Summary - For the fiscal year 2025, the company is projected to achieve revenues of RMB 7.67 billion, with a year-on-year growth of 3.6% [7][14]. - Net profit attributable to shareholders is expected to reach RMB 310 million in 2025, reflecting a growth of 21.0% [7][14]. - The diluted EPS is forecasted to be RMB 0.18 for 2025, with continued growth expected in subsequent years [7][14]. Market Position and Strategy - Ausnutria's Kabrita brand has maintained over 60% market share in China's imported infant goat milk formula market for seven consecutive years, solidifying its position as a market leader [5][12]. - The company is leveraging its strategic partnership with Yili to enhance its product positioning and market layout, particularly in the cow milk segment [5][12]. - The nutritional products segment is also expanding, with new product launches contributing to revenue growth [5][12].